Ganaplacide + Itraconazole

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Malaria

Conditions

Malaria

Trial Timeline

Nov 18, 2021 โ†’ May 14, 2022

About Ganaplacide + Itraconazole

Ganaplacide + Itraconazole is a phase 1 stage product being developed by Novartis for Malaria. The current trial status is completed. This product is registered under clinical trial identifier NCT05084651. Target conditions include Malaria.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT05084651Phase 1Completed